BRPI0920764A2 - composto com estrutura de carbono spiro quiral, método de preparação do mesmo, e composição farmacêutica contendo o mesmo - Google Patents

composto com estrutura de carbono spiro quiral, método de preparação do mesmo, e composição farmacêutica contendo o mesmo

Info

Publication number: BRPI0920764A2
Authority: BR; Brazil
Prior art keywords: preparation; pharmaceutical composition; composition containing; same; carbon structure
Prior art date: 2008-10-31

Application number

BRPI0920764A

Other languages

English (en)

Inventor

Chan-Soo Shin

Eun-O Kim

heon-joong Kang

Jae-Hwan Lee

Jeong-Ah Kim

Jeong-Ho Hong

Jun-Young Hong

Jung-Rae Rho

Sang-Mi Oh

Seung-Bum Park

Original Assignee

Snu R&Db Foundation

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-10-31

Filing date

2009-10-30

Publication date

2015-12-22

2009-10-30 Application filed by Snu R&Db Foundation filed Critical Snu R&Db Foundation

2015-12-22 Publication of BRPI0920764A2 publication Critical patent/BRPI0920764A2/pt

Links

-1 carbon structure compound Chemical class 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
125000003003 spiro group Chemical group 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/10—Spiro-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Hematology (AREA)
Obesity (AREA)
Diabetes (AREA)
Child & Adolescent Psychology (AREA)
Gastroenterology & Hepatology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

BRPI0920764A 2008-10-31 2009-10-30 composto com estrutura de carbono spiro quiral, método de preparação do mesmo, e composição farmacêutica contendo o mesmo BRPI0920764A2 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
KR20080107821		2008-10-31
PCT/KR2009/006357 WO2010050783A2 (ko)	2008-10-31	2009-10-30	스파이로키랄 탄소 골격을 갖는 신규한 화합물, 그의 제조방법 및 그를 포함하는 약제학적 조성물
KR1020090104124A KR101149878B1 (ko)	2008-10-31	2009-10-30	스파이로키랄 탄소 골격을 갖는 신규한 화합물, 그의 제조방법 및 그를 포함하는 약제학적 조성물

Publications (1)

Publication Number	Publication Date
BRPI0920764A2 true BRPI0920764A2 (pt)	2015-12-22

Family

ID=42275585

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0920764A BRPI0920764A2 (pt)	2008-10-31	2009-10-30	composto com estrutura de carbono spiro quiral, método de preparação do mesmo, e composição farmacêutica contendo o mesmo

Country Status (11)

Country	Link
US (1)	US8703813B2 (pt)
EP (1)	EP2363400B1 (pt)
JP (1)	JP2012507509A (pt)
KR (1)	KR101149878B1 (pt)
CN (1)	CN102203099B (pt)
AU (1)	AU2009310544A1 (pt)
BR (1)	BRPI0920764A2 (pt)
CA (1)	CA2742364A1 (pt)
ES (1)	ES2423196T3 (pt)
RU (1)	RU2492173C2 (pt)
WO (1)	WO2010050783A2 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2012033353A2 (ko) *	2010-09-07	2012-03-15	서울대학교 산학협력단	세스터터핀 화합물 및 이들 물질의 용도
KR101647507B1 (ko)	2014-10-20	2016-08-10	건국대학교 글로컬산학협력단	정전용량 기반의 혈관삽입형 바이오센서를 이용한 심혈관 질환 진단 데이터 획득 시스템 및 방법
CN104873499B (zh) *	2015-06-11	2017-10-17	中国医学科学院医药生物技术研究所	一种上调Runx2 转录活性的化合物在防治骨质疏松中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5328929A (en) *	1993-07-02	1994-07-12	Arizona Board Of Regents	Isolation and structure of spongistatin 2, spongistatin 3, spongistatin 4 and spongistatin 6
JP3331028B2 (ja)	1993-11-16	2002-10-07	第一製薬株式会社	スピロ化合物及びその製法
JP2003514033A (ja) *	1999-11-15	2003-04-15	パーカーヒューズインスティテュート	癌治療用のホルボキサゾール誘導体
JP2005035895A (ja) *	2003-07-15	2005-02-10	Institute Of Physical & Chemical Research	高カルシウム血症および骨疾患治療剤
US7485631B2 (en) *	2005-04-21	2009-02-03	The Trustees Of The University Of Pennsylvania	Phorboxazole compounds and methods of their preparation
JP4696870B2 (ja) *	2005-11-21	2011-06-08	Ｊｆｅスチール株式会社	高強度鋼板及びその製造方法
JP3988833B2 (ja)	2006-12-01	2007-10-10	日東電工株式会社	新規セスキテルペン系化合物、その製造方法及び組成物

2009
- 2009-10-30 JP JP2011534397A patent/JP2012507509A/ja not_active Ceased
- 2009-10-30 CN CN200980143890.9A patent/CN102203099B/zh not_active Expired - Fee Related
- 2009-10-30 RU RU2011121877/04A patent/RU2492173C2/ru not_active IP Right Cessation
- 2009-10-30 US US13/126,979 patent/US8703813B2/en active Active
- 2009-10-30 AU AU2009310544A patent/AU2009310544A1/en not_active Abandoned
- 2009-10-30 KR KR1020090104124A patent/KR101149878B1/ko not_active Expired - Fee Related
- 2009-10-30 BR BRPI0920764A patent/BRPI0920764A2/pt not_active IP Right Cessation
- 2009-10-30 ES ES09823863T patent/ES2423196T3/es active Active
- 2009-10-30 CA CA2742364A patent/CA2742364A1/en not_active Abandoned
- 2009-10-30 EP EP09823863.7A patent/EP2363400B1/en not_active Not-in-force
- 2009-10-30 WO PCT/KR2009/006357 patent/WO2010050783A2/ko not_active Ceased

Also Published As

Publication number	Publication date
EP2363400A4 (en)	2012-04-18
CA2742364A1 (en)	2010-05-06
CN102203099A (zh)	2011-09-28
EP2363400B1 (en)	2013-06-12
RU2011121877A (ru)	2012-12-10
AU2009310544A1 (en)	2010-05-06
KR101149878B1 (ko)	2012-05-24
JP2012507509A (ja)	2012-03-29
EP2363400A2 (en)	2011-09-07
ES2423196T3 (es)	2013-09-18
RU2492173C2 (ru)	2013-09-10
US8703813B2 (en)	2014-04-22
CN102203099B (zh)	2014-03-12
WO2010050783A3 (ko)	2010-09-10
KR20100048934A (ko)	2010-05-11
WO2010050783A2 (ko)	2010-05-06
US20110218240A1 (en)	2011-09-08

Similar Documents

Publication	Publication Date	Title
DK2282994T3 (da)	2013-09-30	3-aminocarbazolforbindelse, farmaceutisk sammensætning indeholdende forbindelsen samt fremstillingsmetode derfor
BRPI0917579A2 (pt)	2016-10-11	composto, composição farmacêutica, métodos, e, uso de um composto
BRPI0920263A2 (pt)	2016-07-12	composto, uso do composto, composição, e, método
EP2429987A4 (en)	2012-10-03	AMIDE COMPOUND, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
BRPI0821115A2 (pt)	2015-06-16	Composto derivado de aminotriazol, medicamento, composição farmacêutica e uso do composto
BRPI0919942A2 (pt)	2014-12-23	Composto, composição farmacêutica, e, uso de um composto
BRPI0907562A2 (pt)	2017-05-23	composto, composição farmacêutica, e, uso de um composto
BRPI0921375A2 (pt)	2015-12-29	composto, composição farmacêutica, e, uso de um composto
BRPI0906962A2 (pt)	2015-07-14	Composto, e, composição farmacêutica
BRPI0906556A2 (pt)	2015-07-07	Composto, e, composição farmacêutica
BRPI0917001A2 (pt)	2016-02-16	composto, composição farmacêutica, e, uso de um composto ou uma composição farmacêutica
BR112012022878A2 (pt)	2016-06-14	composto, composição farmacêutica, uso do compostos e método de tratamento
BRPI0918360A2 (pt)	2017-10-10	composto, composição farmacêutica e usos de um composto
BRPI0917315A2 (pt)	2015-11-17	anticorpo, composicao farmaceutico, e, uso de uma composicao farmaceutica
BRPI0913739A2 (pt)	2015-08-18	Composição líquida, método, e, uso de composição
CL2007002377A1 (es)	2008-04-04	Compuestos derivados de quinazolina; procedimiento de preparacion; composicion farmaceutica; y su uso como anticancerigeno.
BR112012022879A2 (pt)	2016-06-14	composto, composição farmacêutica, uso do composto e método de tratamento
BRPI0921879A2 (pt)	2018-10-16	composto, composição farmacêutica , e, uso de um composto
BR112012004335A2 (pt)	2015-09-08	composto, composição farmacêutica, e, uso do composto.
BRPI0809661A2 (pt)	2014-10-14	Composição farmacêutica estabilizada contendo pregabalina
BRPI0917681A2 (pt)	2015-08-04	Composto, e, composição farmacêutica
BRPI0915120A2 (pt)	2016-07-26	composto derivado de oxima, uso do referido composto e composição farmacêutica
BRPI1008039A2 (pt)	2016-10-04	composto, mistura, composição farmacêutica, e, uso de um coposto, de uma mistura ou de uma composição farmacêutica
BRPI0906937A2 (pt)	2016-04-19	composto, composição farmacêutica, e, uso de um composto
BRPI0910179A2 (pt)	2016-01-19	composto de amina, composição farmacêutica e uso do composto de amina

Legal Events

Date	Code	Title	Description
2016-09-13	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE AS 6A E 7A ANUIDADES.
2017-01-10	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.